47 studies found for:    " May 25, 2011":" June 24, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: DNA.HIVA;   Biological: MVA.HIVA
22 Unknown  Victim Impact Modules for Jail Inmates
Conditions: Substance Abuse;   HIV Risk;   Shame;   Guilt;   Empathy;   Criminogenic Thinking
Interventions: Behavioral: Impact of Crime Modules;   Behavioral: TAU
23 Active, not recruiting Jail-Based Impact of Crime Intervention
Conditions: Substance Abuse;   HIV Risk;   Criminogenic Thinking;   Shame;   Guilt;   Empathy
Interventions: Behavioral: MI plus IOC group intervention;   Behavioral: Motivational Interview only
24 Active, not recruiting A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: Trans-theoretical Process of Change Model-self;   Behavioral: Trans-theoretical Process of Change Model - interviewer
25 Active, not recruiting HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068;   Drug: Raltegravir;   Drug: Tenofovir;   Drug: Ritonavir;   Drug: Atazanavir
26 Completed
Has Results
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)
Condition: Human Immunodeficiency Virus Infection
Intervention:
27 Unknown  Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates
Conditions: Impulsive Behavior;   Substance Abuse;   HIV Risk Behavior;   Anxiety;   Depression;   Criminogenic Thinking
Interventions: Behavioral: REVAMP;   Behavioral: TAU
28 Active, not recruiting Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
Conditions: Influenza, Human;   Human Immunodeficiency Virus I Infection
Intervention:
29 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
30 Completed
Has Results
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
Condition: HIV-1 Patients
Intervention:
31 Unknown  GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
Conditions: HIV-1 Infected Patients;   Fold-change Resistance;   Resistance Mutations
Intervention:
32 Completed Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
Conditions: HIV;   Human Papillomavirus
Interventions: Biological: Gardasil;   Biological: Cervarix
33 Completed HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies
Condition: HIV
Interventions: Behavioral: Monetary Incentive;   Behavioral: Questionnaire Timing;   Behavioral: HIV Test Offering
34 Recruiting Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
Conditions: HIV;   Alcohol Use Disorder
Interventions: Drug: oral naltrexone;   Drug: Placebo pill
35 Active, not recruiting Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Conditions: HIV;   Impaired Cognition
Interventions: Drug: standard care;   Drug: novel treatment
36 Active, not recruiting A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections
Condition: HIV
Intervention: Behavioral: Project Bridge
37 Completed Therapy to Elevate CD4 Counts in HIV-1 Disease
Condition: HIV Disease
Intervention: Biological: alpha-1-Proteinase Inhibitor
38 Active, not recruiting REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Condition: HIV Infection
Interventions: Drug: Atripla (r);   Drug: Efavirenz;   Drug: Truvada;   Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC;   Drug: Rifampin/isoniazid FDC
39 Completed Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
40 Completed Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Indicates status has not been verified in more than two years